Sai Life Sciences Financials
NSE: SAILIFE
₹1,584.30
As on 04-Sep-2026 15:58IST
Market cap
₹33,664 Cr
Revenue (TTM)
₹2,250 Cr
P/E Ratio
93.1
P/B Ratio
13.2
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,250.36
|
2,192.49
|
1,694.57
|
1,465.18
|
1,217.14
|
869.59
|
|||||
|
Total Income
|
2,293.13
|
2,266.90
|
1,731.35
|
1,494.27
|
1,245.11
|
897.74
|
|||||
|
Total Expenditure
|
1,592.13
|
1,584.97
|
1,286.73
|
1,178.04
|
1,048.24
|
744.71
|
|||||
|
EBITDA
|
658.23
|
607.53
|
407.84
|
287.14
|
168.90
|
124.89
|
|||||
|
Depreciation
|
175.07
|
166.86
|
138.57
|
119.44
|
99.43
|
90.16
|
|||||
|
EBIT
|
483.16
|
440.67
|
269.27
|
167.70
|
69.47
|
34.73
|
|||||
|
Interest
|
34.51
|
40.88
|
78.34
|
87.56
|
81.02
|
53.18
|
|||||
|
Other Income
|
42.77
|
74.40
|
36.78
|
29.09
|
27.97
|
28.15
|
|||||
|
Exceptional Items
|
-8.00
|
-8.00
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
483.42
|
466.19
|
227.70
|
109.23
|
16.41
|
9.70
|
|||||
|
Provision for Tax
|
121.68
|
117.28
|
57.57
|
26.43
|
6.42
|
3.47
|
|||||
|
Profit after Tax
|
361.74
|
348.91
|
170.13
|
82.81
|
9.99
|
6.23
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
361.74
|
348.91
|
170.13
|
82.81
|
9.99
|
6.23
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,483.69
|
2,483.69
|
2,128.35
|
975.14
|
888.09
|
878.57
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
308.77
|
321.65
|
321.62
|
593.61
|
531.64
|
565.36
|
|||||
|
Current Liabilities
|
833.68
|
904.59
|
759.14
|
739.90
|
758.85
|
714.60
|
|||||
|
Total Liabilities
|
3,626.14
|
3,709.93
|
3,209.12
|
2,308.66
|
2,178.59
|
2,158.52
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,827.93
|
2,228.49
|
1,677.96
|
1,363.55
|
1,214.64
|
1,213.15
|
|||||
|
Current Assets
|
1,410.53
|
1,481.44
|
1,531.16
|
945.11
|
963.95
|
945.38
|
|||||
|
Total Assets
|
3,626.14
|
3,709.93
|
3,209.12
|
2,308.66
|
2,178.59
|
2,158.52
|
|||||
|
Total Debt*
|
--
|
95.13
|
128.64
|
710.16
|
699.23
|
751.32
|
|||||
|
Net Current Assets
|
576.85
|
576.85
|
772.02
|
205.21
|
205.10
|
230.78
|
|||||
|
Contingent Liabilities
|
--
|
97.31
|
58.11
|
24.08
|
15.69
|
19.02
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
509.13
|
314.05
|
263.09
|
219.40
|
104.87
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-395.41
|
-536.67
|
-192.38
|
-101.78
|
-103.71
|
|||||
|
Cash from Financing Activities
|
--
|
-123.68
|
301.43
|
-95.30
|
-200.65
|
71.92
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-9.96
|
78.81
|
-24.59
|
-83.03
|
73.08
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
17.41
|
16.48
|
8.16
|
4.69
|
0.18
|
0.35
|
|||||
|
Cash EPS (₹)
|
17.03
|
24.35
|
14.81
|
11.45
|
6.21
|
5.49
|
|||||
|
Adjusted Book Value (₹)
|
120.19
|
117.07
|
101.88
|
54.59
|
49.83
|
49.52
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
24.04
|
15.07
|
148.95
|
120.58
|
59.73
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-7.13
|
-9.20
|
-10.01
|
17.75
|
-76.94
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
20.97
|
15.53
|
12.03
|
6.06
|
4.02
|
|||||
|
ROE (%)
|
15.47
|
15.16
|
11.02
|
8.99
|
1.14
|
0.72
|
|||||
|
ROA (%)
|
10.66
|
10.09
|
6.17
|
3.69
|
0.46
|
0.31
|
|||||
|
EBIT Margin (%)
|
21.47
|
20.10
|
15.89
|
11.45
|
5.71
|
3.99
|
|||||
|
Net Margin (%)
|
15.77
|
15.39
|
9.83
|
5.54
|
0.80
|
0.69
|
|||||
|
Cash Profit Margin (%)
|
--
|
23.50
|
18.20
|
13.78
|
8.99
|
11.08
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
17.74
|
29.38
|
15.66
|
20.38
|
39.97
|
14.44
|
|||||
|
EBIT Growth (%)
|
36.01
|
63.66
|
60.56
|
141.42
|
100.04
|
-60.43
|
|||||
|
Net Profit Growth (%)
|
50.65
|
105.08
|
105.45
|
729.00
|
60.44
|
-89.81
|
|||||
|
EPS Growth (%)
|
43.61
|
101.82
|
74.12
|
2,574.71
|
-50.58
|
-89.88
|
|||||
|
Book Value Growth (%)
|
--
|
16.76
|
120.22
|
9.78
|
1.01
|
1.59
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
93.06
|
58.91
|
93.36
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
13.19
|
8.29
|
7.48
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
48.00
|
30.12
|
34.97
|
1.80
|
3.20
|
4.18
|
|||||
|
Close Price (₹)
|
1,234.30
|
972.00
|
760.85
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
1,260.00
|
1,084.00
|
808.80
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
763.85
|
635.30
|
549.00
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
33,664.48
|
20,554.39
|
15,882.87
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.04
|
0.06
|
0.74
|
0.80
|
0.86
|
|||||
|
Short term debt to equity ratio
|
--
|
0.03
|
0.06
|
0.38
|
0.42
|
0.46
|
|||||
|
Current Ratio
|
1.69
|
1.64
|
2.02
|
1.28
|
1.27
|
1.32
|
|||||
|
Quick Ratio
|
1.51
|
1.47
|
1.86
|
1.16
|
1.09
|
1.15
|
|||||
|
Interest Coverage
|
15.01
|
12.40
|
3.91
|
2.25
|
1.20
|
1.18
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.60
|
17.04
|
20.94
|
17.48
|
23.34
|
27.93
|
|||||
|
Asset Turnover
|
0.66
|
0.63
|
0.61
|
0.65
|
0.56
|
0.44
|
|||||
|
Receivable days
|
--
|
60.56
|
65.73
|
67.19
|
79.01
|
94.14
|
|||||
|
Inventory Days
|
--
|
22.43
|
22.19
|
28.23
|
39.95
|
42.65
|
|||||
|
Payable days
|
--
|
194.31
|
180.62
|
142.25
|
176.27
|
230.68
|
|||||
|
Cash Conversion Cycle
|
--
|
-111.32
|
-92.70
|
-46.83
|
-57.30
|
-93.89
|